-
-
GALAFOLD
- QTY 14
- 123 MG
- Capsule
- Near 77381
MIGALASTAT (mi GAL a stat) treats Fabry Disease. It works by replacing an enzyme normally made by the body, which reduces the buildup fatty substances (lipids) in the eyes, kidneys, heart, and other tissues. This decreases symptoms and the risk of serious health problems.
Change Location
Set Price Drop Alert for:
GALAFOLD
- QTY 14
- 123 MG
- Capsule
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
GALAFOLD
- QTY 14
- 123 MG
- Capsule
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
GALAFOLD Lifestyle Interactions
-
Migalastat 123mg, Oral capsule
• Interaction: Caffeine-containing Foods/Beverages• Severity: Moderate• Notes for Consumers: Do not take or drink any product that contains caffeine within 2 hours of taking your medication. When taken at the same time, your medication may not work as well for you. Talk with your care team if you feel your medication is no longer working well.• Notes for Professionals: Advise patients to avoid consuming caffeine at least 2 hours before or after taking migalastat to give a minimum 4 hour fast. Simultaneous use may decrease migalastat exposure and efficacy. Coadministration of 190 mg caffeine reduced the mean migalastat AUC by 55%. -
Migalastat 123mg, Oral capsule
• Interaction: Food• Severity: Moderate• Notes for Consumers: Do not eat food within 2 hours of taking your medication. When taken at the same time, your medication may not work as well for you. Talk with your care team if you feel your medication is no longer working well.• Notes for Professionals: Advise patients to take migalastat on an empty stomach and avoid food at least 2 hours before or after taking migalastat to give a minimum 4 hour fast. Simultaneous use may decrease migalastat exposure and efficacy.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
